Market Research Future published a research report on Non-Invasive Prenatal Testing (NIPT) Market Research Report - Global Forecast till 2025. Report gives a clear picture of current market scenario which includes past and estimated future market size. The report provides detail information and strategies of top key players in the industry. The report also gives a broad study about different markets segments and regions.
According to MRFR analysis, the global NIPT market is expected to register a CAGR of 12.8% during the forecast period of 2019 to 2025 and was valued at USD 3,514.765 million in 2018.
Non-Invasive Prenatal Testing (NIPT) Market Overview
NIPT plays an essential role in complex patient emergencies condition for monitoring the fetal growth and condition. These devices and procedures are used for applications. As a result of technological advancements, the global maternal mortality rate has reduced approximately less than 70 per 100,000 live births. The NIPT has benefited resolve issues related DNA deletion and other chromosomal disorders.
Segmentation
The global NIPT market has been segmented based on product type, techniques, application, and end user.
The market, based on product type, has been divided into devices, consumables, and others. The devices segment has been further classified as ultrasound devices, polymerase chain reaction instruments, microarrays, sequencing systems, and others. The devices are likely to hold the maximum market share in the global NIPT market. Consumables are further segmented into assay kits & reagents, disposables, and others.
The global NIPT market on the basis of techniques has been segregated into biochemical screening tests and ultrasound detection.
On the basis of application, the global non-invasive prenatal testing market is segmented into trisomy microdeletion syndrome and others.
The end user segment of the market consists of diagnostic laboratories, hospitals, and research institutes. The diagnostic laboratories segment is expected to hold the largest share of the market as these centers are primary locations for patients receiving non-invasive prenatal testing.
Key Players
Some of the key players in the global NIPT market are Laboratory Corporation of America Holdings (US), Natera, Inc, Yourgene Health (UK), Centogene Holding AG [CENTOGENE AG ] (Germany), Agilent Technologies, Inc, Beijing Genomics Institute (China), General Electric Company [GE Healthcare] (US), Illumina, Inc, Perkinelmer, Inc, PhytoHealth Corporation (Taiwan), Tarsa Therapeutics, Inc, Thermo Fisher Scientific, Inc, and F Hoffman-La Roche Ltd.
Browse full report @ https://www.marketresearchfuture.com/reports/non-invasive-prenatal-testing-market-8371
Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is anticipated to hold the largest market share owing to the increasing awareness about advanced NIPT procedures. The non-invasive prenatal testing market is divided into the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada.
Browse Other Healthcare Related Reports
Population Health Management Market – Global Forecast 2018 – 2023
Vocal Biomarkers Market – Global Forecast 2017 – 2023
About Market Research Future:
MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Market Research Future
https://www.marketresearchfuture.com/